In vitro teratogenicity testing using a 3D, embryo-like gastruloid system.

Area of Science:

• Developmental biology
• Toxicology
• Biotechnology

Background:

• Pharmaceuticals require teratogenicity testing for patient safety.
• Current animal-free in vitro models lack developmental context.
• 3D gastruloids offer a more accurate model of early embryonic development.

Purpose of the Study:

• To evaluate the potential of 3D gastruloids for in vitro teratogenicity assessment.
• To compare the efficacy of mouse and human gastruloids in predicting drug effects.
• To validate gastruloids as a high-throughput screening tool for developmental toxicity.

Main Methods:

• Utilized mouse and human gastruloid models.
• Exposed gastruloids to seven reference compounds with known teratogenic risks.
• Quantitatively assessed morphological changes and gene expression (SOX2, BRA, SOX17) in response to compounds.

Main Results:

• Observed significant morphological alterations, including reduced elongation and size, upon compound exposure.
• Detected aberrant gene expression indicative of differentiation defects and disrupted axial patterning.
• Gastruloids demonstrated species-specific responses mirroring known in vivo susceptibilities.

Conclusions:

• 3D gastruloids provide a robust in vitro model for teratogenicity assessment.
• This model effectively recapitulates key aspects of early embryonic development.
• Gastruloids represent a promising novel system for high-throughput drug safety screening.